Assessment of the protective effect of sunscreen by measuring UV-biomarkers
- Conditions
- one
- Registration Number
- NL-OMON25722
- Lead Sponsor
- one
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Other
- Sex
- Not specified
- Target Recruitment
- 12
Between 18 and 65 years of age
-Fitzpatrick skin type II or III
-Free of any dermatological or systemic disorder which would interfere with the results, at the discretion of the investigator
-Individual who has read, understood, and signed an informed consent document relating to the specific study to which he/she is subscribing
-Willingness to actively participate in the study and come to the scheduled visits
-Willingness to discontinue the use of detergents (e.g. soaps) and cosmetics products (e.g. creams, moisturizers) in the treatment area throughout the course of the study
-Willingness to avoid any exposure of the test area to artificial or natural ultraviolet light throughout the course of the study
-Individual with no known abnormal response to sunlight (e.g. polymorphic eruption) or to sunscreen (ingredients of sunscreen)
-Taking medication which in the opinion of the investigator would mask or interfere with the results
-With chronic skin allergies
-With suntan of sunburn
-Breastfeeding
-Pregnancy or the intention to become pregnant over the duration of the study
-Participation in, or being in the waiting period for another study
-Individual with moles, tattoos, scars, irritated skin, hairs, etc. at the test area that could influence the investigation.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method rocanic acid isomers, immunological mediators, and angiogenesis factors in the stratum corneum at baseline and after UVR.
- Secondary Outcome Measures
Name Time Method